UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 206

Sortiert nach

Hepatitis E

The Lancet (British edition), 2012-06, Vol.379 (9835), p.2477-2488

2012

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Efficacy of a Hepatitis E Vaccine

The New England journal of medicine, 2015-03, Vol.372 (10), p.914-922

2015

Link zum Volltext

Verfügbarkeit prüfen

Rat Hepatitis E Virus as Cause of Persistent Hepatitis after Liver Transplant

Emerging infectious diseases, 2018-12, Vol.24 (12), p.2241-2250

2018

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration

Science translational medicine, 2016-08, Vol.8 (352), p.352ra108

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial

JNCI : Journal of the National Cancer Institute, 2020-02, Vol.112 (2), p.145-153

2020

Link zum Volltext

Verfügbarkeit prüfen

Virus-mimetic nanovesicles as a versatile antigen-delivery system

Proceedings of the National Academy of Sciences - PNAS, 2015-11, Vol.112 (45), p.E6129-E6138

2015

Link zum Volltext

Verfügbarkeit prüfen

Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease

PloS one, 2015-06, Vol.10 (6), p.e0130209-e0130209

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial

The Lancet (British edition), 2010-09, Vol.376 (9744), p.895-902

2010

Link zum Volltext

Verfügbarkeit prüfen

Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells

Emerging microbes & infections, 2020-01, Vol.9 (1), p.2105-2113

2020

Link zum Volltext

Verfügbarkeit prüfen

Multimodal investigation of rat hepatitis E virus antigenicity: Implications for infection, diagnostics, and vaccine efficacy

Journal of hepatology, 2021-06, Vol.74 (6), p.1315-1324

2021

Link zum Volltext

Verfügbarkeit prüfen

Prognosis of hepatitis E infection in patients with chronic liver disease: A meta‐analysis

Journal of viral hepatitis, 2023-02, Vol.30 (2), p.101-107

2023

Link zum Volltext

Verfügbarkeit prüfen

Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors

Journal of hepatology, 2012-10, Vol.57 (4), p.720-729

2012

Link zum Volltext

Verfügbarkeit prüfen

Quantitative evaluation of protective antibody response induced by hepatitis E vaccine in humans

Nature communications, 2020-08, Vol.11 (1), p.3971-3971, Article 3971

2020

Link zum Volltext

Verfügbarkeit prüfen

EGFR‐targeted CAR‐T cells are potent and specific in suppressing triple‐negative breast cancer both in vitro and in vivo

Clinical & translational immunology, 2020-05, Vol.9 (5), p.e01135-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Baseline Level of Hepatitis B Core Antibody Predicts Spontaneous Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg‐Positive Children With a Normal Alanine Aminotransferase Level

Hepatology (Baltimore, Md.), 2019-12, Vol.70 (6), p.1903-1912

2019

Link zum Volltext

Verfügbarkeit prüfen

Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis

BMC cancer, 2022-03, Vol.22 (1), p.287-287, Article 287

2022

Link zum Volltext

Verfügbarkeit prüfen

Estrogen Receptor α Represses Transcription of HBV Genes via Interaction With Hepatocyte Nuclear Factor 4α

Gastroenterology (New York, N.Y. 1943), 2012-04, Vol.142 (4), p.989-998.e4

2012

Link zum Volltext

Verfügbarkeit prüfen

The development of a recombinant hepatitis E vaccine HEV 239

Human vaccines & immunotherapeutics, 2015-04, Vol.11 (4), p.908-914

2015

Link zum Volltext

Verfügbarkeit prüfen

Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein

Nature communications, 2017-11, Vol.8 (1), p.1877-7, Article 1877

2017

Link zum Volltext

Verfügbarkeit prüfen

Role of quantitative hepatitis B core antibody levels in predicting significant liver inflammation in chronic hepatitis B patients with normal or near‐normal alanine aminotransferase levels

Hepatology research, 2018-02, Vol.48 (3), p.E133-E145

2018

Link zum Volltext

Verfügbarkeit prüfen

An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 prospectively followed recipients

Transfusion (Philadelphia, Pa.), 2013-10, Vol.53 (10pt2), p.2505-2511

2013

Link zum Volltext

Verfügbarkeit prüfen

Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18–26 years in China: a randomised blinded clinical trial

The Lancet infectious diseases, 2023-11, Vol.23 (11), p.1313-1322

2023

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B virus X protein targets Bcl-2 proteins to increase intracellular calcium, required for virus replication and cell death induction

Proceedings of the National Academy of Sciences - PNAS, 2012-11, Vol.109 (45), p.18471-18476

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 206

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(164)
Mit Volltextzugriff
(155)

Publikationsform

Artikel
(205)
Tagungsberichte
(1)

Sprache

Englisch
(167)
Chinesisch
(42)
Japanisch
(25)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Hepatitis E

Long-Term Efficacy of a Hepatitis E Vaccine

Rat Hepatitis E Virus as Cause of Persistent Hepatitis after Liver Transplant

Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration

Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial

Virus-mimetic nanovesicles as a versatile antigen-delivery system

Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease

Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial

Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells

Multimodal investigation of rat hepatitis E virus antigenicity: Implications for infection, diagnostics, and vaccine efficacy

Prognosis of hepatitis E infection in patients with chronic liver disease: A meta‐analysis

Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors

Quantitative evaluation of protective antibody response induced by hepatitis E vaccine in humans

EGFR‐targeted CAR‐T cells are potent and specific in suppressing triple‐negative breast cancer both in vitro and in vivo

Baseline Level of Hepatitis B Core Antibody Predicts Spontaneous Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg‐Positive Children With a Normal Alanine Aminotransferase Level

Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial

Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis

Estrogen Receptor α Represses Transcription of HBV Genes via Interaction With Hepatocyte Nuclear Factor 4α

The development of a recombinant hepatitis E vaccine HEV 239

Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein

Role of quantitative hepatitis B core antibody levels in predicting significant liver inflammation in chronic hepatitis B patients with normal or near‐normal alanine aminotransferase levels

An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 prospectively followed recipients

Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18–26 years in China: a randomised blinded clinical trial

Hepatitis B virus X protein targets Bcl-2 proteins to increase intracellular calcium, required for virus replication and cell death induction

A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice

Suchergebnisse filtern